Radiotracer, Gamma Camera Study Of Chemotherapy: Results “Scinti”-llating
This article was originally published in The Gray Sheet
Patients responding to neoadjuvant chemotherapy can reliably be identified using the radiotracer Tc99m sestamibi (DuPont's Cardiolite) and a gamma camera like Philips Medical Systems' Prism 2000 XP, according to a study published in the June issue of The Journal of Nuclear Medicine
You may also be interested in...
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.
Lilly has launched a similar antibody product, but demand is expected to outpace supply for the foreseeable future.